Cells · 2021 · 127 citations · 28 references
Life SciencesInfectious DiseasesMolecular BiologyInnate ImmunityMolecular VirologyVirologyAntiviral ImmunityInnate Immune ResponseInnate Immune Signaling PathwaysInterferon ResponsesRig-i-like ReceptorsViral PathogenesisAntiviral Innate SignalingAntiviral Interferon ResponsesHost Antiviral ResponseInhibition Of Interferon ResponsesRig-i SignalingRig-i-like Receptor SignalingSars-cov-2 InfectionType I Interferon Induction
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the coronavirus disease 2019 (COVID-19) that has resulted in the current pandemic. The lack of highly efficacious antiviral drugs that can manage this ongoing global emergency gives urgency to establishing a comprehensive understanding of the molecular pathogenesis of SARS-CoV-2. We characterized the role of the nucleocapsid protein (N) of SARS-CoV-2 in modulating antiviral immunity. Overexpression of SARS-CoV-2 N resulted in the attenuation of retinoic acid inducible gene-I (RIG-I)-like receptor-mediated interferon (IFN) production and IFN-induced gene expression. Similar to the SARS-CoV-1 N protein, SARS-CoV-2 N suppressed the interaction between tripartate motif protein 25 (TRIM25) and RIG-I. Furthermore, SARS-CoV-2 N inhibited polyinosinic: polycytidylic acid [poly(I:C)]-mediated IFN signaling at the level of Tank-binding kinase 1 (TBK1) and interfered with the association between TBK1 and interferon regulatory factor 3 (IRF3), subsequently preventing the nuclear translocation of IRF3. We further found that both type I and III IFN production induced by either the influenza virus lacking the nonstructural protein 1 or the Zika virus were suppressed by the SARS-CoV-2 N protein. Our findings provide insights into the molecular function of the SARS-CoV-2 N protein with respect to counteracting the host antiviral immune response.
28
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang, Yeming Wang, Xingwang Li et al. · The Lancet · 2020 · 51.8K citations · Full text
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Na Zhu, Dingyu Zhang, Xingwang Li et al. · New England Journal of Medicine · 2020 · 30.4K citations · Full text
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
Daniel Blanco-Melo, Benjamin E. Nilsson-Payant, Wen‐Chun Liu et al. · Cell · 2020 · 4.5K citations · Full text
Jasper Fuk‐Woo Chan, Kin‐Hang Kok, Zheng Zhu et al. · Emerging Microbes & Infections · 2020 · 3.3K citations · Full text
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
Jérôme Hadjadj, Nader Yatim, Laura Barnabei et al. · Science · 2020 · 3.2K citations · Full text